Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great post. I completely agree. Nailed it!
July 5th...same day 11,260,040 shares from the last PP become free to trade. Cost .25 CDN
Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke
insert-text-here
Algernon requests EOP2 meeting on April 26th.
April 26th + 70 days = July 5th
Algernon 11,260,040 Unit PP 4 month hold expires July 5th.
Coincidence??
insert-text-here
insert-text-here
Once the data has been analyzed, the Company will receive the trial results and after a brief internal review, the data will be released to the public
Buy low...Sell high
I'm back baby. Loaded up today and ready for the ride!!
Looks like a calendar year Q2, 2020 start date...
https://www.youtube.com/embed/fKSQ1kmCTvM
Halted...another PP???
The latest PR was confirmation that Dr. Randy Purves has earned his stock options.
Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development. Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ?9-tetrahydrocannabinol (“THC”) analyte capture from human breath. THC is found in breath in generally low quantities. The Company has significantly improved sample collection methods using the breath collection unit (“BCU”) and other newly developed techniques.
A primary interest of Dr. Purves is to use his expertise in FAIMS and small molecule analysis to improve quantification methods of analytes in challenging matrices.
Patent examiner considers the application still does not comply with the Patent act.
http://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2887841/images.html?page=1&frenchDocType=Poursuite-Amendment&englishDocType=Prosecution-Amendment&modificationDate=20181203&scale=25&rotation=0&type=basic_search&objectName=A1001001A19G03B01748H34138&numPages=5&query=cannabix&start=&num=
approval of a special resolution to amend the quorum required for the transaction of business at a meeting of shareholders by replacing Section 8.3 of the Company’s Articles
News...More testing
Maybe Kal's next move for the medical device is a licensing/partnership/royalty deal with GrowMax. Now that he hijacked the company and got 25 million burning a hole in his pocket...
I am not buying that the BCU is for research/testing purpose only. If you take a look at Owlstone and their process of performing breath biopsy's. They have two devices that are needed to produce the results, a breath collection unit (Reciva) and a FAIMS analyzer (Lonestar or ultraFAIMS). The two units interface together, sound familiar. Over $70 million has been invested in developing Owlstone Medical’s FAIMS technology. Now to me it seems like Frost/Yost work with Owlstone is helping Cannabix down a similar path to complete our goal.
Reproducibility is key for any analytical technique, and standardization of breath collection is key to enable the breath diagnostics field to perform robust breath biomarker discovery for a range of medical diagnostics applications.To address the challenges in sampling breath, Owlstone Medical formed the Breathe Free Consortium, a group of 100 multi-disciplinary experts in breath diagnostics, in order to jointly develop the ReCIVA Breath Sampler as the industry standard for the reliable collection of breath samples.
Collect breath samples using ReCIVA and analyse using ultraFAIMS-MS for fast, quantitative analysis without lengthy analysis times associated with chromatographic separation.
My hope is the BCU will collect the breath sample data then send it wirelessly to the FAIMS device for instant roadside analysis.
The new breath collection unit (“BCU”) will provide key physiologic breath sample data under different environmental conditions to determine the effects such parameters on a ?9-tetrahydrocannabinol (“THC”) breath sample.
The BCU real time data display wirelessly connects to an android device for live data streaming and this data can be sent to the cloud for further analysis and storage.
HALTED!!
IMO...It appears to me that some type of legal agreement was made by Cannabix in January. Why was it not disclosed on the monthly report?
https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_Feb_5_2019.pdf?NG43aSvrK6wEb9Bg6FJIF0A5DxU_tFff
Can anyone speak French?
http://www.adc54.org/images/txt/20190131235515.pdf
For this purpose, any user who wishes to acquire medical and legal cannabis from CANNABIX
TECHNOLOGIES INC (Canada) must provide a copy of their identity card and proof
home.
It looks like the covert weapons detection market is heating up. Has anyone heard about the Liberty Defense Technologies HEXWAVE product. It looks very similar to PAT1. Fortunately it's looking like 2020 before they become legitimate competition.
https://www.libertydefense.com/wp-content/uploads/Liberty-Defense-Corporate-Presentation.pdf
Quote from stockhouse
looks like more information from MSvanton
RE:RE:If you build it - they will come
I have to agree with you - the party is lacking big time and needs a boost - I can tell you why though - I spoke with the powers that be last night - if you go to stockwatch and other news outlets you will see that Wednesdays news was taken down - again, they have been instructed and its being harshly enforced to keep the lowest profile and to basically say nothing because they have met with the FDA, human trials are once again underway and results are pending - it all comes down to the next little bit - there is a buyer on standby and they are waiting to pull the trigger on this and I have been assured that a buyout is underway - I don't want to post the name of the company and I'm sure you can understand why but their last buyout was for $775 million and the product was less adequate than what IME has developed - its coming - GL ALL
Looks like Kal is fully loaded with shares and warrants again. I'm so glad I contributed half of my shares towards his 14 million. What a joke...
http://www.otcmarkets.com/financialReportViewer?symbol=BTHCF&id=209451
IMO...This is far from big institution. More like "Friends of Bullrun". They also bought a huge chunk of BLOZF last PP.
Who else was developing the FAIMS prototype? MistyWest???
The Company has been working with Richard Yost and the University of Florida to assist with the transition of the University taking over the FAIMS prototype development work.
Final Prospectus is out on Sedar
The Company’s intended objectives moving forward will focus primarily on execution of commercialization of CMR-1 and the integration of additional sensor innovations on a common multi-sensor threat detection platform. The Company is currently looking at a number of transactions relating to this strategy. The Company plans to embark on joint research and development on a multi-year program with the international defence contractor referred to above. This work may also include the integration of that defence contractor’s technology. The Company also plans to be focused on production, supply chain management and inventory, as well as significant overseas market development.
There have been and will continue to be technical hurdles as the CMR-1 technology is a new technology and is dependent on complex mathematical and physics equations. The net proceeds from the 2017 Bought Deal Financing and the 2018 Bought Deal Financing have allowed the Company to move ahead on tackling these challenges, some more quickly than others, and there are dependencies between streams of work which has caused unforeseen delays to the timelines set out in the 2017 Bought Deal Financing and the 2018 Bought Deal Financing. Particular progress has been made on CMR-1 hardware configuration (i.e., with the Company’s 6th generation antenna) which has resulted in an advancement in performance and has allowed the Company to look to early stage pilot deployments of the CMR-1. Also, the Company is in the final stages of documentation for submission for relevant government approval with respect to its agreement in principle with the international defence contractor (see “Recent Developments”). If approved, this will be a significant milestone in unlocking a substantial multi-year co-funded innovation pipeline
I believe half my shares were stolen from me for a reason. Why did they take them? I have a hunch were closer to a finished product and sales then you think.
This is HUGE. Going Research Use Only means NO FDA Approval required!!! Once the device is completed it can be manufactured/sold to research scientists worldwide without the wait. I don't really care what its used for, as long as there is a huge demand for the product. $$$$$
Prospectus is out on Sedar